Virginia Tech Intellectual Properties (VTIP) with LINK + LICENSE + LAUNCH’s Proo...
Vladimir Drinfeld, the Harry Pratt Judson Distinguished Service Professor of Mat...
With Arexvy, GSK has achieved the same status in Europe as it did with the desir...
Following the recent trend among Japanese firms, such as West Japan Railway, Tok...
FibroGen continues to face challenges in its clinical endeavors, now extending i...
German drugmaker Bayer has entered an agreement with Acuitas Therapeutics, the f...
Arvinas is moving forward with its plans to expand the development of its ARV-76...
The fast track designation enables increased communication with the FDA througho...
KT430 delivers a functional copy of the MTM1 gene through a new MyoAAV capsid to...
The Prescription Cost Analysis also highlighted that the drug with the largest i...
The committee overwhelmingly supported nirsevimab’s risk-benefit profile in both...
VEVYE is a topical anti-inflammatory and immunomodulating ophthalmic drug solution.
Upstream Bio’s UPB-101 is currently being assessed in a Phase 1b trial to treat ...
The new 244,000ft² facility represents the company’s second significant expansio...
The vaccine has been developed by WestVac Biopharma along with the West China Me...
David McInerney, Cassie Commercial Manager, explains clinical data management ch...
